These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8086240)

  • 21. Combined effect of soy isoflavones and vitamin D3 on bone loss in ovariectomized rats.
    Chang KL; Hu YC; Hsieh BS; Cheng HL; Hsu HW; Huang LW; Su SJ
    Nutrition; 2013 Jan; 29(1):250-7. PubMed ID: 22858193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between increased endogenous parathormone levels and bone density in postmenopausal women treated with bisphosphonates.
    Coin A; Veronese N; Bolzetta F; De Rui M; Manzato E; Sergi G
    Panminerva Med; 2012 Dec; 54(4):277-82. PubMed ID: 23123579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
    Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
    J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1 alpha-hydroxylase reserve in postmenopausal osteoporosis.
    Civitelli R; Agnusdei D; Nardi P; Zacchei F; Avioli LV; Gennari C
    Calcif Tissue Int; 1988 Feb; 42(2):77-86. PubMed ID: 3127028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of intermittent rat parathyroid hormone (1-34) treatment on low bone mass due to oestrogen or androgen depletion in skeletally mature rats.
    Montero M; Serfati D; Luna S; Díaz-Curiel M; Carrascal MT; Gomez S; De la Piedra C
    Aging Male; 2010 Mar; 13(1):59-73. PubMed ID: 20148746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmenopausal and senile osteoporosis: current concepts of etiology and treatment.
    Riggs BL
    Endocrinol Jpn; 1979 Jun; 26(Suppl):31-41. PubMed ID: 467347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. μCT-based, in vivo dynamic bone histomorphometry allows 3D evaluation of the early responses of bone resorption and formation to PTH and alendronate combination therapy.
    de Bakker CM; Altman AR; Tseng WJ; Tribble MB; Li C; Chandra A; Qin L; Liu XS
    Bone; 2015 Apr; 73():198-207. PubMed ID: 25554598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parathyroid hormone increases bone formation and improves mineral balance in vitamin D-deficient female rats.
    Toromanoff A; Ammann P; Mosekilde L; Thomsen JS; Riond JL
    Endocrinology; 1997 Jun; 138(6):2449-57. PubMed ID: 9165035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of change patterns of microcomputed tomography 3-dimensional bone parameters as a high-throughput tool to evaluate antiosteoporotic effects of agents at an early stage of ovariectomy-induced osteoporosis in mice.
    Xiang A; Kanematsu M; Mitamura M; Kikkawa H; Asano S; Kinoshita M
    Invest Radiol; 2006 Sep; 41(9):704-12. PubMed ID: 16896306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.
    Kurland ES; Cosman F; McMahon DJ; Rosen CJ; Lindsay R; Bilezikian JP
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3069-76. PubMed ID: 10999788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone mass preservation with high-dose cholecalciferol and dietary calcium in HIV patients following antiretroviral therapy. Is it possible?
    Mela Q; Ruggiero V; Montaldo L; Pisano U; Matta L; Maria Pasetto C; Onali S; Cacace E; Carta MG; Barca L; Chessa L
    HIV Clin Trials; 2018 Oct; 19(5):188-196. PubMed ID: 30445888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of phytoestrogen, genistein combined with calcium and vitamin D3 on preventing osteoporosis in ovariectomized mice].
    Wang Q; Zhang Y; Gao L; Xue Y
    Wei Sheng Yan Jiu; 2011 Sep; 40(5):587-90. PubMed ID: 22043708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
    Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S
    Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption.
    Rude RK; Kirchen ME; Gruber HE; Meyer MH; Luck JS; Crawford DL
    Magnes Res; 1999 Dec; 12(4):257-67. PubMed ID: 10612083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H; Shen V; Dempster DW; Lindsay R
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALX 111: ALX1-11, parathyroid hormone (1-84) - NPS Allelix, PREOS, PTH, recombinant human parathyroid hormone, rhPTH (1-84).
    Adis International Ltd
    Drugs R D; 2003; 4(4):231-5. PubMed ID: 12848587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.